SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-23-005678
Filing Date
2023-04-13
Accepted
2023-04-13 19:52:53
Documents
1
Period of Report
2023-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 3505
  Complete submission text file 0001567619-23-005678.txt   4826
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2614 BOSTON POST ROAD SUITE #33B GUILFORD CT 06437
Business Address
Agarwal Rashmi (Reporting) CIK: 0001973399 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38410 | Film No.: 23819479